The study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal ...

because when patients get metastatic disease, we don't often perform surgeries to cut it out." Moreover, surgery is a very ...

About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company ...

The tumor is partially obstructing his colon, and an MRI revealed that Burge had metastatic disease on his liver. His treatment plan includes chemotherapy before and after his surgeries.

The outlook for people with the disease isn’t as life-limiting ... you may experience new symptoms. Metastases in the lungs, brain, bones, or liver might each cause different symptoms.

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR ...

These DNA-carrying EVs are taken up by macrophages in the liver, activating anti ... milieu can prime other sites for metastasis. Leptomeningeal metastatic disease (LMD) arises secondary to ...

During a Case-Based Roundtable® event, Daniel J. George, MD and participants discussed combination regimens for intermediate ...

According to Intera, this allows local chemotherapy concentrations to reach liver metastases in levels about ... treat various forms of this disease with minimal systemic side effects and improved ...

Download a PDF of the Plain Language Summary. A total of 303 patients who had not previously received systemic treatment for metastatic disease were randomly assigned to receive nivolumab plus ...

with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that ...

Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver ...